Chromen-based TNF-α converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation

Cited 39 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorK Chun-
dc.contributor.authorSong Kyu Park-
dc.contributor.authorHwan Mook Kim-
dc.contributor.authorY Choi-
dc.contributor.authorM H Kim-
dc.contributor.authorC H Park-
dc.contributor.authorB Y Joe-
dc.contributor.authorT G Chun-
dc.contributor.authorH M Choi-
dc.contributor.authorH Y Lee-
dc.contributor.authorS H Hong-
dc.contributor.authorM S Kim-
dc.contributor.authorK Y Nam-
dc.contributor.authorG Han-
dc.date.accessioned2017-04-19T09:09:06Z-
dc.date.available2017-04-19T09:09:06Z-
dc.date.issued2008-
dc.identifier.issn0968-0896-
dc.identifier.uri10.1016/j.bmc.2007.09.014ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/8298-
dc.description.abstractA series of coumarin types MMP inhibitors were designed based on gelastatin hydroxamates (1) and evaluated for TACE, cellular TNF-α, and NO inhibitory activities. Among them, compounds 9b had potent inhibitory activities in enzymatic and cellular assays and good selectivity to MMP-2 and MMP-9. Further investigation of 9b will be carried out for its efficacy in RA animal model system.-
dc.publisherElsevier-
dc.titleChromen-based TNF-α converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation-
dc.title.alternativeChromen-based TNF-α converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry-
dc.citation.number1-
dc.citation.endPage535-
dc.citation.startPage530-
dc.citation.volume16-
dc.contributor.affiliatedAuthorSong Kyu Park-
dc.contributor.affiliatedAuthorHwan Mook Kim-
dc.contributor.alternativeName전광우-
dc.contributor.alternativeName박성규-
dc.contributor.alternativeName김환묵-
dc.contributor.alternativeName최용석-
dc.contributor.alternativeName김명화-
dc.contributor.alternativeName박춘호-
dc.contributor.alternativeName제보영-
dc.contributor.alternativeName전태규-
dc.contributor.alternativeName최현무-
dc.contributor.alternativeName이희윤-
dc.contributor.alternativeName홍성희-
dc.contributor.alternativeName김명숙-
dc.contributor.alternativeName남계엽-
dc.contributor.alternativeName한균희-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry, vol. 16, no. 1, pp. 530-535-
dc.identifier.doi10.1016/j.bmc.2007.09.014-
dc.subject.keywordcoumarin derivatives-
dc.subject.keywordgelastatin hydroxamates-
dc.subject.keywordmetalloproteinase-2 (MMP-2)-
dc.subject.keywordmetalloproteinase-9 (MMP-9)-
dc.subject.keywordrheumatoid arthritis (RA)-
dc.subject.keywordTNF-α converting enzyme (TACE)-
dc.subject.localcoumarin derivatives-
dc.subject.localgelastatin hydroxamates-
dc.subject.localmetalloproteinase-2 (MMP-2)-
dc.subject.localmetalloproteinase-9 (MMP-9)-
dc.subject.localmetalloproteinase-9-
dc.subject.localRheumatoid Arthritis-
dc.subject.localRheumatoid arthritis-
dc.subject.localrheumatoid arthritis (RA)-
dc.subject.localrheumatoid arthritis-
dc.subject.localTNFα converting enzyme-
dc.subject.localTNF-α converting enzyme (TACE)-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.